As we alluded to in our article, 1 we firmly believe that the only effective way to determine whether a protocol of interventions associated with the PneuX ™ system is superior to 'best practice' is through a well-designed multi-centre randomised controlled trial. 1 and would like to share our early observations from a study (reference 13/WA/0264) in the intensive care unit (ICU) at our institution.
Letters to the editor
We are running a pilot study of EMS, using a similar protocol to that previously described, 2 using the muscle stimulator model Mi-theta600 (CefarCompex, DJO Global, France). This approved feasibility study has been designed for us to gain more experience before embarking on a randomised controlled trial. Six patients have so far been recruited, but in all six we have failed to locate a motor point in the quadriceps femoris muscle group, so that none have therefore been entered into the study. We have had extensive and ongoing assistance from DJO Global. The equipment works on healthy volunteers, indicating that the inability to locate a motor point is due to changes in the critically ill patient' s muscle rather than technical failure.
We note that the majority of studies discussed in Edwards' review commenced EMS within 72 hours of ICU admission. The patients in our study were recruited from between 72 hours and two weeks. We therefore presume that the failure to obtain a motor point is due to ICU-acquired weakness (ICU-AW), and that the ICU-AW happens very early in critical illness. This would be consistent with recent work suggesting that the biochemical changes in ICU-AW may happen very early in the course of a critical illness. ICU-AW includes Critical Illness Myopathy and Polyneuropathy (CIM and CIPN respectively), and postulated mechanisms include circulatory impairment leading to reduced oxygen and nutrient delivery to the neurone, and functional changes in the muscle itself, including muscle membrane inexcitability, decreased contractility, altered sarcoplasmic reticulum function, and mitochondrial dysfunction. 3 Electro-diagnostic studies show reduction or absence of motor action potential amplitudes as the muscle membrane becomes electrically inexcitable; these changes can happen within 96 hours of admission. 4 We remain optimistic about EMS as part of a treatment strategy for ICU-AW but our observations are consistent with emerging evidence that the pathological changes occur within the first few days of a critical illness and that EMS should probably be started within this time for maximal benefit.
